Wells Fargo’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Wells Fargo’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,500	Closed	-$32K	–	7674
2024 Q1	$32K	Sell	1,500 -3,500	-70%	-$41.9K	﹤0.01%	5424
2023 Q4	$48K	Buy	+5,000	New	+$24.3K	﹤0.01%	5291
2020 Q3	–	Sell	-15,517	Closed	-$271K	–	7068
2020 Q2	$271K	Buy	+15,517	New	+$270K	﹤0.01%	4727

Wells Fargo's FUSN Position: Q2 2024 in Review

Wells Fargo sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 1,500 shares — an estimated $32K sold.

Wells Fargo first reported a position in FUSN in Q2 2020 and held it in 3 quarters. The position peaked at $271K in Q2 2020. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Wells Fargo reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Wells Fargo sold 1,500 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $32K.
Wells Fargo first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2020 and held it in 3 quarters.
Wells Fargo's Fusion Pharmaceuticals Inc. Common Shares position peaked at $271K in Q2 2020.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.